UNIGE document Scientific Article
previous document  unige:104787  next document
add to browser collection
Title

Sulforaphane improves disrupted ER-mitochondria interactions and suppresses exaggerated hepatic glucose production
Authors
Tubbs, Emily
Axelsson, Annika S
Vial, Guillaume
Wollheim, Claes
Rieusset, Jennifer
Rosengren, Anders H
Published in Molecular and Cellular Endocrinology. 2018, vol. 461, p. 205-214
Abstract Exaggerated hepatic glucose production is one of the hallmarks of type 2 diabetes. Sulforaphane (SFN) has been suggested as a new potential anti-diabetic compound. However, the effects of SFN in hepatocytes are yet unclear. Accumulating evidence points to the close structural contacts between the ER and mitochondria, known as mitochondria-associated ER membranes (MAMs), as important hubs for hepatic metabolism. We wanted to investigate whether SFN could affect hepatic glucose production and MAMs.
Identifiers
PMID: 28923347
Full text
Article (Published version) (2.3 MB) - document accessible for UNIGE members only Limited access to UNIGE
Structures
Faculté de médecine / Section de médecine fondamentale / Département de physiologie cellulaire et métabolisme
Citation
(ISO format) 		TUBBS, Emily et al. Sulforaphane improves disrupted ER-mitochondria interactions and suppresses exaggerated hepatic glucose production. In: Molecular and Cellular Endocrinology, 2018, vol. 461, p. 205-214. doi: 10.1016/j.mce.2017.09.016 https://archive-ouverte.unige.ch/unige:104787

252 hits

0 download

Contact an author

Update request

Update

Deposited on : 2018-05-31

Export document
Format :
Citation style :